Marine animals and plants are rich sources of bioactive natural products. Haterumalides and biselides, isolated from Okinawan marine animals, are 14-membered macrolides with strong cytotoxicity against human cancer cell lines. This review highlights the isolation, structures, bioactivities, and total synthesis of haterumalides, biselides, and related natural products.
Introduction
Marine animals and plants are rich sources of bioactive natural products. 1 The search for antitumor substances from marine organisms has been conducted worldwide, and many cytotoxic and/or antitumor marine natural products have been isolated, some of which are promising for anticancer chemotherapy. Some examples are halichondrin B, discodermolide, and cryptophycin from sponges; didemnin B, aplidine, and ecteinascidin 743 from ascidians; bryostatin 1 from a bryozoan; and dolastatin 10 and kahalalide F from sea hare. Because many of these compounds were isolated from tropical or subtropical seas, marine organisms in tropical and subtropical zones have attracted the interest of natural product chemists and pharmaceutical scientists.
Isolation and Biological Activities of Haterumalides, Biselides, and Related Compounds
In 1999, the first haterumalide family was isolated from an Okinawan ascidian by Ueda and Hu 2 and from an Okinawan sponge by Uemura and coworkers ( Figure 1) . 3 Ueda and Hu isolated haterumalide B (6) from the Okinawan ascidian Lissoclinum sp. and determined the structure with partial stereochemistry spectroscopically. Haterumalide B (6) completely inhibited the first cleavage of fertilized sea urchin eggs at a concentration of 0.01 µg/mL. At the same time, Uemura and coworkers isolated haterumalides NA (1), NB (2), NC (3), ND (4) , and NE (5) from the Okinawan sponge Ircinia sp. Although these compounds were isolated as very minute components of the animal, they helped elucidate the absolute stereostructure of haterumalide NA (1) by detailed spectroscopic analysis and the modified Mosher method, 4 as shown in structural formula 1. Later, they revised the relative stereochemistry and determined the absolute stereochemistry of haterumalide NA in an organic synthetic manner. 5 Haterumalide NA (1) exhibited cytotoxicity against P388 cells, with an IC 50 of 0.32 µg/mL, and moderate acute toxicity against mice, with an LD 99 of 0.24 g/kg. That same year, an anti-oomycete compound, oocydin A (12), was isolated from South American epiphyte Serratia marcescens by Strobel and coworkers. 6 The gross structure with partial stereochemistry was determined by spectroscopic analysis. Thaning and coworkers screened 300 bacterial isolates for the ability to suppress apothecial formation of Sclerotinia sclerotiorum and isolated haterumalide NA/oocydin A from the soil bacterium Serratia plymuthica as an active compound. 7 Levenfors and coworkers isolated haterumalide X from the soil bacterium Serratia plymuthia along with haterumalides NA (1), B (6), and NE (5). 8 Haterumalide X was found to be the Z isomer of the C16 double bond in haterumalide NA (1). They could not collect antifungal data on haterumalide X because this compound is easily converted into haterumalide NA (1). Later, researchers at Fujisawa Pharmaceutical Company isolated an antimicrobial component, FR177391 (13) , from the soil bacterium Serratia liquefaciens. The structure was determined by X-ray crystallographic analysis of the propylamide derivative. 9 This compound is the enantiomer of haterumalide NA (1) . They reported on a detailed study of its anti-hyperlipidemic activity 10 and the microbial conversion into 20-hydroxy FR177391 (14) . 11 In addition, they identified its molecular target as protein phosphatase 2A (PP2A). 12 It is notable that haterumalides NA (1) and B (6), which are marine natural products, are levorotatory, while oocydin A (12) and FR177391 (13) from an epiphyte of an aquatic plant and a soil bacterium are dextrorotatory. In 2004, Kigoshi and coworkers isolated biselides A (7) and B (8), oxygenated analogs of haterumalides, from the Okinawan ascidian Didemnidae sp. and determined their structures by detailed spectroscopic analysis (Figure 1) . 13 The next year, they reported the isolation of three more analogs, biselides C (9)-E (11) and compared the cytotoxicity of biselides A (7) and C (9) with that of haterumalide NA methyl ester (15). 14 The order of the cytotoxicity is haterumalide NA methyl ester (15) > biselide A (7) > biselide C (9) . Among the tested cell lines, biselide A (7) showed the strongest cytotoxicity against human colon cancer DLD-1 (0.513 µΜ). Interestingly, haterumalide NA (1) showed strong toxicity against brine shrimp, with an LD 50 of 0.6 µg/mL, while biselides A (7) and C (9) showed no toxicity against brine shrimp, even at 50 µg/mL. It is worth noting that 20-hydroxy FR177331 (14) , the microbial oxidation compound of FR177331 (13) , has the same planar structure as biselide C (9). 
Synthetic Studies of Haterumalides

Studies in Kigoshi's Laboratory
The first report concerning haterumalides from the Kigoshi laboratory described an enantioselective synthesis of ent-haterumalide NA methyl ester (15). 5 This synthesis revised the stereochemistry of haterumalide NA and determined its absolute stereochemistry. Their synthetic route to ent-haterumalide NA methyl ester (15) involved a key macrocyclization at C2-C3 using an intramolecular Reformatsky-type reaction (Scheme 1). They also developed a coupling between aldehyde 16 and iodoolefin 17 at C15-C16 using a Nozaki-Hiyama-Kishi coupling. The starting point for this work was the construction of the tetrahydrofuran unit (Scheme 2). Mono-MPM ether 22 was synthesized from commercially available (+)-2,3-O-isopropylidene-L-threitol. After transformation into the corresponding iodide, C1 homologation was achieved by using the FAMSO carbanion to afford sulfoxide 23. Sequential acidic methanolysis and hydrolysis afforded a hemiacetal 24. The Wittig reaction of 24 and cyclization provided a 5.3:1 diastereomeric mixture of tetrahydrofurans, which were separated after silylation to afford the desired trans-tetrahydrofuran 26 and cis-isomer. The latter was isomerized into a 1:1 mixture under basic conditions. The desired trans-tetrahydrofuran 26 was quantitatively converted into bromide 21 in three steps. The coupling reaction between the tetrahydrofuran unit 21 and a carbanion generated from Z-alkenylsilane 20 gave alkenylsilane 19 (Scheme 3). The stereoselective construction of a chloroolefin unit from alkenylsilane 19 was achieved by a modification of Tamao's procedure 16 for conversion of an alkenylsilane to a bromoolefin. Kigoshi et al. found that the addition of a catalytic amount of water was important for the reaction to be reproducible. Acidic hydrolysis of 27 and subsequent Dess-Martin oxidation afforded a labile aldehyde, which was converted into the Z-conjugated ester 28 by using the Still-modified Horner-Wadsworth-Emmons reaction. 17 The DIBAL reduction of 28 gave an allylic alcohol, the hydroxy group of which was protected as an MMTr ether to afford compound 29 quantitatively. The silyl group in 29 was removed, and the resulting alcohol was converted into a bromo ester. The MMTr group was removed, and the resulting allylic alcohol was oxidized to afford the conjugated aldehyde 18, a precursor of the intramolecular Reformatsky-type reaction. Cyclization under Honda's conditions, 18 Et 2 Zn-RhCl(PPh 3 ) 3 , followed by the addition of Ac 2 O to trap the reactive products afforded the desired cyclized product in 9% yield along with the (3R, 4Z) and (4E) isomers (Scheme 4). The MPM group was removed to give alcohol 30. The Nozaki-Hiyama-Kishi coupling reaction of iodide 17 and aldehyde 16 derived from 30 afforded the coupling product 15 (57%, S:R = 11:1). The major isomer, (15S)-15, was found to be the enantiomer of the naturally occurring haterumalide NA methyl ester 15 upon comparison of their spectral data. These results determined the total absolute stereochemistry, which revised the proposed structure. 
Studies in Snider's Laboratory
Snider et al. reported the total synthesis of ent-haterumalide NA methyl ester (15). 19 Their strategy involved a key fragment coupling at C5-C6 using a Stille coupling (Scheme 5). 20 They also accomplished macrocyclization of a seco acid by Yamaguchi conditions. The synthetic route reported by Snider begins with the preparation of optically active vinylstannane 33 (Scheme 5). The Z-methyl-substituted alkene unit 36 was prepared by the Cu-catalyzed methylmagnesation of propargyl alcohol 35 22 followed by iodinolysis. Iodoalkene 36 was oxidized with MnO 2 to afford an iodoaldehyde. The asymmetric aldol reaction of the iodoaldehyde with the ketene silyl acetal 37 by using Kiyooka's oxaborolidinone 38 provided the β-hydroxy phenyl ester 39. 23 The allylic hydroxyl group of 39 was protected as a TBS ether, and the resulting vinyl iodide was converted into the vinylstannane 33. In contrast, an optically active alcohol 34 was prepared via an asymmetric aldol reaction between the O-TMS dienolate 40 and acrolein (41) by using Carreira's Ti(IV) catalyst 42, 24 or kinetic resolution of the racemic alcohol 43 via Sharpless asymmetric epoxidation (Scheme 7). Alcohol 34 was converted to a keto ester, the stereoselective reduction of which with Et 2 BOMe and NaBH 4 afforded syn diol 44 (Scheme 8). Diol 44 was protected as an acetonide, and the ester group was transformed into an alkyl iodide group in a sequence of reactions to afford iodide 45. The coupling reaction between iodide 45 and acetylide 46 generated from the tert-butyldimethylsilyl propargyl ether gave a coupling compound (92%). The acetonide group was removed to give diol 47 by using BF 3 ·OEt 2 and propanedithiol. The stereoselective intramolecular iodoetherification of 47 afforded iodomethyltetrahydrofuran 48 (81%) in >90% de. After acetylation of the secondary hydroxyl group, the iodomethyl group was transformed into the desired hydroxymethyl group by using m-CPBA, and the acetyl group was cleaved to afford diol 49. Diol 49 was protected as an acetonide, and the TBS group was removed to give the propargylic alcohol. A regioselective hydroalumination of the propargylic alcohol by using Red-Al ® and subsequent treatment with NCS furnished the desired Z-chloro allylic alcohol. Reaction of the allylic alcohol with MsCl, Et 3 N, and then LiCl afforded dichloride 32. A Stille coupling reaction 20 between dichloride 32 and vinylstannane 33 with Pd 2 dba 3 and AsPh 3 afforded 50 (65%) and the corresponding (E)-isomer (Scheme 9). The acetonide group was removed by using CSA to give a diol, and selective tritylation of the primary hydroxy group in the diol and hydrolysis of the phenyl ester afforded the seco acid 31. The macrolactonization of 31 was accomplished by the Yamaguchi method 21 to give the desired lactone 51 along with the dimer and the trimer. The TBS group in 51 was removed, and the resulting alcohol was converted into an acetate. The trityl group was removed to give the primary alcohol 30, which is the key intermediate in Kigoshi's synthesis. 5 From this point on, the earlier synthesis was followed. Oxidation with Dess-Martin periodinane and Nozaki-Hiyama-Kishi coupling 15 with iodide 17 afforded 30-40% of haterumalide NA methyl ester (15) after HPLC purification. 2)
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Scheme 11. Mechanism of the Kaneda reaction
The synthetic route reported by Hoye begins with the preparation of a 3-hydroxy tetrahydrofuran derivative by Roush's method (Scheme 12). 28 The [3+2] annulation of the allylsilane 57 with α-(p-methoxybenzyloxy)acetoaldehyde 56 was performed using SnCl 4 as the Lewis acid catalyst to provide the 2,5-trans-substituted tetrahydrofuran 58. The TBS groups in 58 were removed, and the resulting diol was converted into an acetonide. The phenyldimethylsilyl group was oxidized by Tamao-Woerpel oxidation 29 to provide a secondary alcohol. After inversion of the resulting secondary alcohol under Mitsunobu conditions, 30 the MPM ether group was converted into a propargyl group to give compound 53. Esterification between 53 and allylic chloride 54 afforded ene-yne 52. This ene-yne compound 52 was a precursor of the Kaneda reaction. 
Conclusion
Although marine natural products are regarded as promising sources of drug discovery, the limited supply of compounds prevents their development as medicines. Haterumalides and biselides are new types of cytotoxic compounds in minute quantities. The studies discussed in this review develop efficient synthetic routes to enable further biological and preclinical evaluations of these compounds. From a synthetic perspective, it is interesting to note that three syntheses employed different strategies to construct a 14-membered macrolactone ring.
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